Bavencio (avelumab) is an immunotherapy medication that’s used for several types of cancers like bladder cancer and kidney cancer. It can also be used for a certain type of skin cancer called Merkel cell carcinoma. Bavencio (avelumab) is most often used by itself, but it can also be used with other anticancer medications in some situations. Some of the more common side effects of Bavencio (avelumab) include tiredness, muscle pain, and joint pain. This medication can also cause serious side effects, like infusion reactions and severe diarrhea.
Bavencio (avelumab) is a type of immunotherapy called a PD-L1 inhibitor. It works against a specific protein on cancer cells called programmed cell death ligand 1 (PD-L1). Cancer cells that have PD-L1 can hide from the body’s immune system. This means that the immune system can’t detect, attack, and kill these cancer cells. As a result, the cancer is able to grow.
When Bavencio (avelumab) attaches to PD-L1 on cancer cells, the cancer cells can’t hide from the immune system anymore. This helps the immune system find and kill cancer cells better. This type of immunotherapy is also known as an immune checkpoint inhibitor.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Note: Side effects from treatment depend on what other medications you’re taking for your cancer. Bavencio (avelumab) is sometimes given along with other anticancer medications.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
No. Chemotherapy is a class of medications that directly kills cancer cells that are quickly multiplying in your body. But Bavencio (avelumab) is a type of immunotherapy. It works differently than chemotherapy. Immunotherapy medications like Bavencio (avelumab) use your body’s own immune system to better find and fight cancer cells.
The infusion process for Bavencio (avelumab) can take at least an hour and a half. Before you receive Bavencio (avelumab), your healthcare provider will give you medications, such as an antihistamine and acetaminophen (Tylenol), to lower your risk of potential infusion reactions. This will take about 30 minutes. Then, your provider will give you the Bavencio (avelumab) infusion, which can take about an hour. But how long it takes to complete the infusion depends on how well you tolerate the medication. If you’re experiencing a reaction to the infusion (e.g., rash, trouble breathing, feeling faint), your provider might need to temporarily slow down or stop the infusion to manage your symptoms. This will make the infusion take longer to finish.
Diarrhea can happen while you’re taking Bavencio (avelumab) because the medication causes your body’s immune system to ramp up so it can kill cancer cells. But since your immune system is in overdrive, it can also attack and affect other areas of your body like your digestive tract, leading to diarrhea. If diarrhea is mild, you can try taking over-the-counter (OTC) antidiarrheal medications like loperamide (Imodium A-D) and avoid foods that might worsen diarrhea. If diarrhea becomes more serious, you should let your healthcare provider know. They might recommend that you take other medications like corticosteroids to help calm down your immune system. If your diarrhea becomes severe and uncontrollable, your healthcare provider might even recommend that you stop taking Bavencio (avelumab) altogether.
Talk with your provider if you’re not sure how long you’ll be taking Bavencio (avelumab). Typically, you'll continue to take Bavencio (avelumab) until it stops working for you (i.e., your cancer doesn’t get better or gets worse) or until you have serious side effects. You might need to pause or stop the medication if you have side effects that you can't tolerate, such as rash, diarrhea, and trouble breathing. Your healthcare provider might also pause or stop your Bavencio (avelumab) treatment if your lab results show that your liver, kidneys, or hormone levels are seriously affected by treatment.
No, Bavencio (avelumab) isn’t safe to take during pregnancy. Animal studies show that the medication can cause harm to the unborn baby. You should avoid becoming pregnant while receiving Bavencio (avelumab) and for at least 1 month after your last dose. Let your provider know right away if you become pregnant during treatment.
There isn’t much information about how Bavencio (avelumab) might affect a nursing baby or your milk supply. But to avoid the potential risk for serious harm, your provider will ask you to stop breastfeeding while you’re taking Bavencio (avelumab) and for at least 1 month after your last dose. Talk with your provider if you have any questions about breastfeeding while receiving this medication.
Bavencio (avelumab) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Bavencio (avelumab) works by ramping up your immune system. But as a result, an overactive immune system can attack any area of your body, which can affect how your organs normally work. Some examples of immune-related side effects include rash, lung problems (trouble breathing), diarrhea, and liver problems, among many others. These side effects can become severe or life-threatening. Immune-related side effects most commonly occur during treatment, but can also still happen even after you’ve stopped treatment with Bavencio (avelumab).
Your healthcare provider will check for the development of immune-related side effects. They’ll monitor your liver, kidney, and thyroid functions through various lab tests during treatment. They’ll also follow up with you on any symptoms you might have. If you experience immune-related side effects, your healthcare provider will examine you to see how severe your symptoms are. Then, they might recommend that you take other medications, like corticosteroids, or stop taking Bavencio (avelumab) altogether.
Bavencio (avelumab) can cause infusion reactions, most commonly fever and chills. In clinical trials with Bavencio (avelumab), about 25% of people experienced an infusion reaction. These reactions are usually mild and tolerable, but in rare cases, they can be serious. They can also happen during or several hours after the infusions. Alert your provider or get medical help right away if you experience any throat tightness, wheezing, trouble breathing, fever, chills, hives, flushing, dizziness, or back or stomach pain.
Taking Bavencio (avelumab) together with Inlyta (axitinib) can raise your risk for severe and life-threatening heart problems. In studies, these problems have included heart attack and heart failure. Because of this risk, your healthcare provider might check your heart function periodically during treatment. Managing any high blood pressure, high cholesterol, or diabetes that you might have can also help lower your risk of heart problems. If you develop serious heart problems, your healthcare provider might recommend stopping treatment with Bavencio (avelumab). Let your healthcare provider know right away if you experience any new or worsening chest pain, shortness of breath, or swelling in the hands, feet, or ankles.
Taking an immunotherapy medication like Bavencio (avelumab) before or after receiving certain types of stem cell transplants can cause serious and fatal problems. One example of a transplant-related complication is graft-versus-host-disease (GVHD). Let your healthcare provider know if you’ve received a stem cell transplant before taking Bavencio (avelumab). Also notify your provider if you’re planning to have a stem cell transplant after treatment with Bavencio (avelumab).
Bavencio (avelumab) can harm an unborn baby when taken during pregnancy. Because of this risk, if you can get pregnant, you should use birth control while receiving Bavencio (avelumab) and for at least 1 month after the last dose. Let your provider know right away if you become pregnant during this time.
The typical dose is 800 mg as an infusion through the vein (intravenous or IV) once every 2 weeks.